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The present study evaluated the antidiabetic effect of daidzein based on its ability to lower 
blood glucose, and influence the regenerative mechanism of pancreatic β-cell in type 1 dia-
betic animal models. Furthermore, the cytotoxic effect of this isoflavone at dose of 100mg/kg 
and 200mg/kg of animal body weight was evaluated in the kidney.  
 
Diabetes mellitus (DM) is a global burden afflicting a substantial population, the 
disease is characterized by the disruption of glucose homeostasis which arises from the 
dysfunction of insulin to act on peripheral tissues (insulin resistance). Disruption of 
glucose homeostasis results in damaging consequences to many vital organs such as 
the kidney, heart, eyes as well as the nervous system and, if left untreated, with a de-
crease in quality of life and an increased rate of mortality [1]. Isoflavones such as dai-
dzein, genistein and glycitein are phytochemicals compounds richly found in legumi-
nous plants, and have been suggested as potential antidiabetic agents owing to their 
ability to reduce hyperglycemia, and to act as an anti-inflammatory and antioxidant 
agents [2]. The present study is aimed to study the possible cytotoxic effect of daidzein 
at different doses, while simultaneously evaluating the regenerative potential of this 
phytochemical in diabetic animal models. Daidzein belongs to isoflavones, phyto-
chemicals identified as potential antidiabetic therapeutic owing to their ability to lower 
hyperglycemia, counter reactive oxygen species, and reduce inflammation. 
Animals were rendered diabetic using a single intraperitoneal injection dose of 
alloxan monohydrate at a dose of 170 mg kg-1 body weight of animal. After 4 weeks of 
treatment with daidzein led to increase their body weight. The biochemical evaluation 
showed a decrease in glucose by 33% and Hb1Ac levels in the blood of diabetic ani-
mals as compared to the diabetic control group. Histological examination of kidney 
showed no structural changes even at doses of 200 mg/kg of animal body weight. Ad-
ditionally, immunohistochemical and morphometric evaluation showed that isofla-
vones enhanced the proliferation of insulin producing cells in the pancreatic islet. It 
could be suggested from the findings that daidzein at dose of 100 or 200 mg/kg of 
animal body weight showed no cytotoxic effects, and act as possible hypoglycemic 
agent in type 1 diabetic animal model. 
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